LincR-PPP2R5C Deficiency Alleviates Airway Remodeling by Inhibiting Epithelial-Mesenchymal Transition Through the PP2A/TGF-β1 Signaling Pathway in Chronic Experimental Allergic Asthma
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 422-433
Abstract
Yuan Q, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):422-433. https://doi.org/10.4168/aair.2024.16.4.422Keywords
Funding Information
- Precision Medicine Research of the National Key Research and Development Plan of China (2016YFC0905800)
- National Natural Science Foundation of China (81970031, 81770031, 82171738)
- Natural Science Foundation of Jiangsu Province (BK20171501, BK2017080, BK20181497)
This publication has 24 references indexed in Scilit:
- Epithelial-mesenchymal transition: Insights into nickel-induced lung diseasesSeminars in Cancer Biology, 2021
- The basic immunology of asthmaCell, 2021
- Selective PP2A Enhancement through Biased Heterotrimer StabilizationCell, 2020
- AsthmaThe Lancet, 2018
- Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cellsCellular Signalling, 2016
- IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthmaJournal of Allergy and Clinical Immunology, 2013
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancerCancer Letters, 2013
- Carcinogenic Aspects of Protein Phosphatase 1 and 2A Inhibitors2009
- Structural Mechanism of Demethylation and Inactivation of Protein Phosphatase 2ACell, 2008
- Epithelial-mesenchymal interactions in the pathogenesis of asthmaJournal of Allergy and Clinical Immunology, 2000